vimarsana.com

Page 148 - தொற்று நோய்கள் சமூகம் ஆஃப் அமெரிக்கா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Latest Q&A COVID-19 from national infectious disease expert from Akron

Infectious diseases organization honors 5 faculty – Washington University School of Medicine in St Louis

Five faculty members at Washington University School of Medicine in St. Louis have been elected fellows of the Infectious Diseases Society of America (IDSA). They are Ernie-Paul Barrette, MD, Jeffrey Henderson, MD, PhD, Stephen Liang, MD, and Hilary Reno, MD, PhD, all associate professors of medicine in the Department of Medicine’s Division of Infectious Diseases; and David Hunstad, MD, director of the infectious diseases division in the Department of Pediatrics. The IDSA honored a total of 181 physicians and scientists as fellows this year. Fellowship in IDSA is considered among the highest honors in the field of infectious diseases. To be considered for the honor, potential fellows must be nominated by their peers and must meet specified criteria that include continuing identification with the field of infectious diseases, national or regional recognition, and publication of scholarly work. Nominees are reviewed and elected by the IDSA Board of Directors.

Answers to Key Questions About a Coronavirus Vaccine

Answers to Key Questions About Coronavirus Vaccine Kevin Loria Consumer Reports has no financial relationship with advertisers on this site. In a remarkably short period of time less than one year scientists managed to design, create, and test several potential vaccines for SARS-CoV-2, the virus that causes COVID-19. On Dec. 11, the Food and Drug Administration issued the first emergency use authorization for a coronavirus vaccine, the one developed by Pfizer and BioNTech. On Dec. 18, the FDA issued a second emergency authorization, for a vaccine developed by Moderna, which is based on similar technology.  On Feb. 27, the FDA issued a third emergency use authorization, this time for a vaccine developed by Johnson & Johnson. This vaccine is based on a different technology from the other two authorized so far, and provides protection after just one shot. The others require two injections.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.